April 2022
Responsible Conduct of Research (RCR) University Mandate
Beginning May 1, 2022, new Human Research protocols cannot be submitted to the Institutional Review Board (IRB) for review and new Animal Research protocol submissions will be held from review until the RCR training requirement is met and/or untrained University of Kentucky research personnel are removed.
Need more information on the University RCR mandate?

Click the button below to view our new video explaining the mandate, the requirements of the mandate, and the penalties. [5:50 minutes]
Not sure which CITI course to enroll in and complete?

Click the button below for our new interactive tool to walk through the steps of logging in to your UK CITI account and enrolling in the RCR course.
Not sure why you are required to complete RCR training?

Click the button below for our new interactive tool and choose the topic that applies to you.
Update on Compliance by College
Complete your RCR training today!
As of April 28, 2022, we have 82.7% compliance across all colleges.

Thank you to all who have completed the training!

*Reminder: RCR training is annual. If you have completed the Basic course, a Refresher course must be completed yearly by your certificate expiration date to stay in compliance.
RCR Team
Watch this short video to learn more about RCR and why it is important!
In the News
PLOS ONE Pulls Five Papers Tied to Alzheimer's Drug Controversy
The retracted studies were coauthored by a scientist who worked on an Alzheimer's therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.

March 31, 2022
The Scientist
By Jef Akst

"Five studies coauthored by Hoau-Yan Wang at the City University of New York and colleagues were pulled from PLOS ONE over concerns about data integrity yesterday (March 30), Retraction Watch reports. Wang, who already had another retraction to his name and who contributed to three other papers that have received expressions of concern, conducted research on an Alzheimer’s therapy called Simufilam that is under development by Austin, Texas–based Cassava Sciences (formerly Pain Therapeutics). Wang is also a paid advisor to the company, and Cassava employee Lindsay Burns is a coauthor on two of the newly retracted papers, which don’t pertain to Simufilam or Alzheimer’s disease.

Citing 'people familiar with the matter,' The Wall Street Journal reported in November that the Securities and Exchange Commission (SEC) is looking into claims that the company submitted Simufilam-related materials to the US Food and Drug Administration (FDA) that included altered data."
Creating a science legacy
Senior academics offer tips to develop world-class research programmes and train successfel protégés.

April 5, 2022
Nature
By Andy Tay

"Researchers have many ways to establish a legacy, including technical innovation, commercialization and changes to scientific culture. All of these approaches require input from talented people who can generate ideas and execute them. Here, five senior research leaders offer their tips on building a legacy in science.
 
KRISTI ANSETH: Build long-term collaborations
Professor of chemical and biological engineering at the University of Colorado Boulder.

Building a science legacy requires the willingness to take risks: many problems are complex, and solving them requires innovative, out-of-the-box approaches.

During my postdoctoral research from 1995 to 1996 at Purdue University in West Lafayette, Indiana, then the Massachusetts Institute of Technology in Cambridge , I decided to get out of my comfort zone and investigate the use of soft materials in biological applications."
U.S. Department Health and Human Services (HHS)
The Office of Research Integrity (ORI)
Research Misconduct Case Summaries
RCR Contacts:
Jen Hill
(859) 257-2978

Jenny Smith
(859) 257-7903

Emily Matuszak
(859) 562-3562
‌